{
  "id": "2f1a0b1a274bfd49",
  "title": "STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy",
  "description": "FDA will take \u201cdecisive steps\u201d to thwart companies from mass marketing unapproved, compounded versions of GLP-1 drugs",
  "content": "FDA will take \u201cdecisive steps\u201d to thwart companies from mass marketing unapproved, compounded versions of GLP-1 drugs",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/06/fda-take-action-against-hims-telehealth-wegovy-compounding/?utm_campaign=rss",
  "published_at": "2026-02-07T01:05:16+00:00",
  "fetched_at": "2026-02-08T00:36:26.400151+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy",
    "description": "FDA will take \u201cdecisive steps\u201d to thwart companies from mass marketing unapproved, compounded versions of GLP-1 drugs",
    "url": "https://www.statnews.com/pharmalot/2026/02/06/fda-take-action-against-hims-telehealth-wegovy-compounding/?utm_campaign=rss",
    "published": "2026-02-07T01:05:16+00:00",
    "source": "STAT"
  }
}